Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Liabilities and Shareholders Equity (2016 - 2026)

Kewaunee Scientific has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $176.0 million for Q1 2026.

  • Quarterly results put Liabilities and Shareholders Equity at $176.0 million for Q1 2026, down 6.97% from a year ago — trailing twelve months through Jan 2026 was $753.2 million (up 27.57% YoY), and the annual figure for FY2025 was $194.7 million, up 44.44%.
  • Liabilities and Shareholders Equity for Q1 2026 was $176.0 million at Kewaunee Scientific, down from $189.1 million in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for KEQU hit a ceiling of $194.7 million in Q2 2025 and a floor of $95.7 million in Q1 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $126.3 million (2024), compared with a mean of $142.1 million.
  • Biggest five-year swings in Liabilities and Shareholders Equity: skyrocketed 49.75% in 2025 and later decreased 6.97% in 2026.
  • Kewaunee Scientific's Liabilities and Shareholders Equity stood at $119.1 million in 2022, then increased by 2.17% to $121.7 million in 2023, then increased by 10.49% to $134.5 million in 2024, then surged by 40.6% to $189.1 million in 2025, then fell by 6.94% to $176.0 million in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $176.0 million (Q1 2026), $189.1 million (Q4 2025), and $193.5 million (Q3 2025) per Business Quant data.